Cellular Uptake, Metabolism and Sensing of Long-Chain Fatty Acids

Abstract

Fatty acids (FAs) are critical nutrients that regulate an organism's health and development in mammal. Long-chain fatty acids (LCFAs) can be divided into saturated and unsaturated fatty acids, depending on whether the carbon chain contains at least 1 double bond. The fatty acids that are required for humans and animals are obtained primarily from dietary sources, and LCFAs are absorbed from outside of cells in mammals. LCFAs enter cells through several mechanisms, including passive diffusion and protein-mediated translocation across the plasma membrane, the latter in which FA translocase (FAT/CD36), plasma membrane FA-binding protein (FABPpm), FA transport protein (FATP), and caveolin-1 are believed to have important functions. The LCFAs that are taken up by cells bind to FA-binding proteins (FABPs) and are transported to the specific organelles, where they are activated into acyl-CoA to target specific metabolic pathways. LCFA-CoAs can be esterified to phospholipids, triacylglycerol, cholesteryl ester, and other specialized lipids. Non-esterified free fatty acids are preferentially stored as triacylglycerol molecules. The main pathway by which fatty acids are catabolized is β-oxidation, which occurs in mitochondria and peroxisomes. stearoyl-CoA desaturase (SCD)-dependent and Fatty acid desaturases (FADS)-dependent fatty acid desaturation pathways coexist in cells and provide metabolic plasticity. The process of fatty acid elongation occurs by cycling through condensation, reduction, dehydration, and reduction. Extracellular LCFA can be mediated by membrane protein G protein-coupled receptor 40 (GPR40) or G protein-coupled receptor 120 (GPR120) to activate mammalian target of rapamycin complex 1 (mTORC1) signaling, and intracellular LCFA's sensor remains to be determined. The crystal structures of a phosphatidic acid phosphatase and a membrane-bound fatty acid elongase-condensing enzyme and other LCFA-related proteins provide important insights into the mechanism of utilization, increasing our understanding of the cellular uptake, metabolism and sensing of LCFAs.

Kidney single-cell transcriptomes uncover SGLT2i-induced metabolic reprogramming via restoring glycolysis and fatty acid oxidation

“…Our study provides new insights into the beneficial effects of SGLT2 inhibition in diabetic kidney disease. (32,33) and fatty acid oxidation (34,35). Created with BioRender.com.…”

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy

“…Transporters involved in cardiomyocyte FA uptake include FA translocase (FAT/CD36), FA binding protein (FABPpm), and FA transport protein (FATP) ( 42 ). FABPpm works with CD36 to facilitate FA transmembrane transport of FAs ( 34 ).…”

Metabolic insights into tumor pathogenesis: Unveiling pan‐cancer metabolism and the potential of untargeted metabolomics

“…Numerous studies have shown that the upregulation of FAS synthesis is a typical metabolic alteration in cancer, which is achieved by the upregulation of transporter proteins and various lipogenic enzymes 40,42–44 . Mammals produce only certain FASs and other FASs notably polyunsaturated FASs, are acquired from the diet by FAS protein transporters (e.g., CD36, SLC27, and plasma membrane FAS‐binding proteins [FASBPs]) 45,46 . Hydrogen sulfide, palmitic acid, and high‐FAst diet‐induced CD36 expression, which enhanced FAS uptake and cancer development 46–49 .…”

“…40,[42][43][44] Mammals produce only certain FASs and other FASs notably polyunsaturated FASs, are acquired from the diet by FAS protein transporters (e.g., CD36, SLC27, and plasma membrane FAS-binding proteins [FASBPs]). 45,46 Hydrogen sulfide, palmitic acid, and high-FAst diet-induced CD36 expression, which enhanced FAS uptake and cancer development. [46][47][48][49] ATPcitrate lyase (ACLY), catalyzes the conversion of citrate and CoA to oxaloacetate and acetyl-CoA, is transcriptionally upregulated by sterol regulatory element binding protein 1 (SREBP1).…”